Research Library

Eight parameters to optimize your “Path to Virtualization” across site- and patient-centric capabilities in this Sponsor Edition eBook

Your Path to Virtualization
Sponsor Edition

The COVID-19 pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions.¹ The urgency to adapt to evolving requirements for both patients and sites is accelerating the adoption of virtualization technologies.

• Are you prepared to adopt a virtualization strategy?
• Can you respond to urgent remote requirements for patients and sites?
• Do you have the technology to support fully remote study conduct?
• Will your strategy meet future standards for transforming trials?

This eBook provides eight parameters to help optimize your path to virtualization across key site- and patient-centric capabilities. To learn more about the capabilities driving a successful response and approach to virtualization, download the eBook now.

[1] http://www.medidata.com/en/insight/covid-19-and-clinical-trials-the-medidata-perspective/#covid-survey

Offered Free by: Medidata, a Dassault Systèmes company
See All Resources from: Medidata, a Dassault Systèmes company